<?xml version="1.0" encoding="UTF-8"?>
<p id="p0495">Synthesized for the first time by Jean Francois Rossignol in the beginning of the 1970s, the 2-acetyloxy-N-(5-nitro-2-thiazolyl) benzamide, sold under the name nitazoxanide (NTZ) 
 <bold>(36)</bold> (
 <xref rid="f0030" ref-type="fig">Fig. 6</xref>), is the result of a structural modification in the antiparasitic niclosamide when a benzene ring is replaced with a nitrothiazole.
 <xref rid="b1170" ref-type="bibr">234</xref>, 
 <xref rid="b1175" ref-type="bibr">235</xref> Developed and sold as antiparasitic, NTZ is also a first line broad spectrum antiviral with good results against parainfluenza, coronavirus, rotavirus, hepatitis and other respiratory infections.
 <xref rid="b1175" ref-type="bibr">235</xref>, 
 <xref rid="b1180" ref-type="bibr">236</xref>, 
 <xref rid="b1185" ref-type="bibr">237</xref>, 
 <xref rid="b1190" ref-type="bibr">238</xref>
</p>
